Institutional investors hold a majority ownership of AMGN through the 81.55% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS INTERNATIONAL Bought 1.3 Million shares of Amgen Inc
PZENA INVESTMENT MANAGEMENT LLC Bought 1.3 Million shares of Amgen Inc
MORGAN STANLEY & CO. LLC Bought 650.2 Thousand shares of Amgen Inc